NEW YORK – OGT, a Sysmex Group company, and Intelliseq said on Wednesday that they have partnered on next-generation sequencing data analysis solutions.
The firms will combine OGT's SureSeq NGS portfolio with Intelliseq's iFlow engine to create a sample-to-report NGS analysis workflow.
Financial and other terms of the deal were not disclosed.
"With the biological and clinical interpretation provided by Intelliseq, SureSeq users will have access to a comprehensive NGS solution that provides more meaningful clinical insight," OGT CEO Adrian Smith said in a statement. "This partnership ensures that SureSeq users can examine any genomic content they want, while receiving the most up-to-date insight from a wide variety of clinical and biological databases."
UK-based OGT offers clinical and diagnostics genomic solutions.
Poland's Intelliseq offers novel algorithms and bioinformatics tools for interpretation of the human genome.